Detalles de la búsqueda
1.
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Br J Cancer
; 130(5): 788-797, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38200233
2.
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Pediatr Blood Cancer
; 62(10): 1739-46, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26153194
3.
Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.
J Pediatr Hematol Oncol
; 36(6): 451-7, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24309609
4.
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
Pediatr Blood Cancer
; 60(11): 1801-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23813912
Resultados
1 -
4
de 4
1
Próxima >
>>